Try our beta test site
1 study found for:    Guillain-Barr� Syndrome
Show Display Options
Rank Status Study
1 Active, not recruiting Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults
Conditions: Prevention of Zika Infection;   Zika-Specific Immune Response
Intervention: Biological: VRC-ZKADNA085-00-VP

Study has passed its completion date and status has not been verified in more than two years.